Holos Life Sciences
Home About Our People Our Science Research News
Contact
HomeAboutOur PeopleOur ScienceResearchNews
Holos Life Sciences
Contact

OBD BOARD RESTRUCTURES TO SUPPORT FUTURE GROWTH

Dr Jon Burrows appointed as Chief Executive Officer as Group strengthens its US presence

Click here for press release.

Lee Harle20 April 2020
Facebook0 Twitter LinkedIn0 Tumblr 0 Likes
Previous

EpiSwitch selected to help identify COVID-19 patients at risk of severe disease and profile patients who will benefit from therapeutic treatment

Lee Harle2 May 2020
Next

Demonstration of the Episwitch™ platform - DLBCL subtyping

Lee Harle17 April 2020
 
Hours
ContactTerms of ServicePrivacy Policy

Registration No. /
Unique Entity Number: 201631849C
ACN 623117224 

 
 

© Copyright Holos Life Sciences 2019